{"id":12275,"date":"2022-07-21T21:45:20","date_gmt":"2022-07-22T01:45:20","guid":{"rendered":"https:\/\/napoli-law.local\/uncategorized\/how-anti-trust-lawsuits-are-impacting-generic-medicines\/"},"modified":"2022-08-18T21:16:03","modified_gmt":"2022-08-19T01:16:03","slug":"anti-trost-davalari-nasil-etkiliyor-jenerik-ilaclar","status":"publish","type":"post","link":"https:\/\/napolilaw.lemonadestand.org\/tr\/article\/anti-trost-davalari-nasil-etkiliyor-jenerik-ilaclar\/","title":{"rendered":"Anti-Tr\u00f6st Davalar\u0131 Jenerik \u0130la\u00e7lar\u0131 Nas\u0131l Etkiliyor?"},"content":{"rendered":"

\"\u00c7e\u015fitli<\/p>\n

 <\/p>\n

Bir ila\u00e7 \u015firketi yeni bir ila\u00e7 ke\u015ffetti\u011finde, patentini al\u0131r. \u0130lac\u0131n icad\u0131ndan 20 y\u0131l sonra<\/a>. Bu s\u00fcre zarf\u0131nda, \u015firketin ilac\u0131 satma konusunda m\u00fcnhas\u0131r hakk\u0131 vard\u0131r ve daha sonra form\u00fcl, di\u011fer \u00fcreticilerin \u00fcretmesi i\u00e7in uygun hale gelir. \u0130deal olarak, bu sistem farmas\u00f6tik ara\u015ft\u0131rmalar\u0131 y\u00fcr\u00fctmek i\u00e7in gereken muazzam yat\u0131r\u0131mlar\u0131 korur ve ila\u00e7lar\u0131n maliyetinin zaman i\u00e7inde d\u00fc\u015fmesi i\u00e7in bir ara\u00e7 sa\u011flar.<\/p>\n

 <\/p>\n

Ancak son y\u0131llarda jenerik ila\u00e7lar tart\u0131\u015fma konusu olmu\u015ftur. Nadir hastal\u0131klar\u0131 tedavi eden ve k\u00fc\u00e7\u00fck bir pazara sahip olan yetim ila\u00e7lar \u015fu \u015fekilde man\u015fetlere konu oldu: Fiyatlar 26 kat artt\u0131<\/a> son yirmi y\u0131lda. Ancak jenerik ila\u00e7 pazar\u0131nda fiyatlar art\u0131yor ve 2014 y\u0131l\u0131nda ba\u015flat\u0131lan bir Adalet Bakanl\u0131\u011f\u0131 soru\u015fturmas\u0131n\u0131n ortaya \u00e7\u0131kan sonu\u00e7lar\u0131 bize bunun nedenini g\u00f6steriyor.<\/p>\n

 <\/p>\n

Soru\u015fturma boyunca Teva, Mylan, Heritage Pharmaceuticals, Dr. Reddy's ve Allergan gibi ila\u00e7 \u015firketleri fiyat sabitleme nedeniyle soru\u015fturuldu ve 2017'de Heritage Pharmaceuticals su\u00e7unu kabul etti. Fiyat belirlemenin eyalet h\u00fck\u00fcmetleri \u00fczerindeki etkisi nedeniyle, 47 eyaletin Ba\u015fsavc\u0131s\u0131 15 ila\u00e7 san\u0131\u011f\u0131 aleyhine dava a\u00e7t\u0131. Fiyat sabitleme, rekabeti azaltmak i\u00e7in pazarlar\u0131 b\u00f6lme konusunda anla\u015fma, minimum fiyatlar\u0131 koruma konusunda anla\u015fma ve jenerik ila\u00e7 \u00fcreticileri aras\u0131ndaki di\u011fer gizli anla\u015fma bi\u00e7imleri, yasa d\u0131\u015f\u0131<\/a>. Patent s\u00fcresi sona erdikten sonra piyasan\u0131n fiyat\u0131 kontrol etmesine izin verme ilkesinin tamam\u0131n\u0131 baltal\u0131yorlar.<\/p>\n

 <\/p>\n

Bu blog ke\u015ffederken<\/a>, belediye y\u00f6netimleri de fiyatlar\u0131n sabitlenmesinden etkileniyor, \u00e7\u00fcnk\u00fc \u00e7o\u011fu kendi kendini sigortal\u0131yor ve sonu\u00e7 olarak \u00e7al\u0131\u015fanlar\u0131 i\u00e7in t\u0131bbi yard\u0131mlar \u00f6d\u00fcyor. T\u0131pk\u0131 eyalet h\u00fck\u00fcmetleri gibi, belediye y\u00f6netimleri de rekabete ayk\u0131r\u0131 uygulamalar yapan jenerik ila\u00e7 \u00fcreticilerinin jenerik ila\u00e7 fiyatlar\u0131n\u0131 suni olarak art\u0131rmas\u0131n\u0131 ve bu \u015fi\u015firilmi\u015f oranlar\u0131 \u00f6demeye zorlayarak zarar g\u00f6rmelerini sa\u011flayabilir.<\/p>\n

 <\/p>\n

Eyalet h\u00fck\u00fcmetleri, yerel y\u00f6netimler ve hatta bireyler bu \u015firketlere kar\u015f\u0131 dava a\u00e7mak i\u00e7in Adalet Bakanl\u0131\u011f\u0131'na kat\u0131ld\u0131k\u00e7a, bu sadece a\u015f\u0131r\u0131 maliyetin y\u00fck\u00fcn\u00fc hafifletmekle kalm\u0131yor, ayn\u0131 zamanda end\u00fcstrinin ayn\u0131 uygulamay\u0131 s\u00fcrd\u00fcrmesini engellemek i\u00e7in de bir sopa sa\u011fl\u0131yor. Fiyat art\u0131\u015flar\u0131ndan olumsuz etkilenen belediye ba\u015fkanlar\u0131 ve bireyler i\u00e7in, toplu dava hukuk firmas\u0131<\/a> tak\u0131m elbise getirmek \u00f6nemli bir ilk ad\u0131md\u0131r.<\/p>","protected":false},"excerpt":{"rendered":"

  Bir ila\u00e7 \u015firketi yeni bir ila\u00e7 ke\u015ffetti\u011finde, ilac\u0131n icad\u0131ndan itibaren 20 y\u0131l s\u00fcreyle ge\u00e7erli olan bir patent al\u0131r. Bu s\u00fcre zarf\u0131nda, \u015firketin \u00f6zel\u2026<\/p>","protected":false},"author":3,"featured_media":12278,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[776],"tags":[],"class_list":["post-12275","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmaceutical-litigation"],"acf":[],"page_builder_type":"gutenberg","gutenberg_data":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts\/12275","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/comments?post=12275"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts\/12275\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media\/12278"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media?parent=12275"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/categories?post=12275"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/tags?post=12275"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}